These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10098952)

  • 1. Transcutaneous nitroglycerine in the treatment of erectile dysfunction: a placebo controlled clinical trial.
    Gramkow J; Lendorf A; Zhu J; Meyhoff HH
    Int J Impot Res; 1999 Feb; 11(1):35-9. PubMed ID: 10098952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minoxidil versus nitroglycerine: a prospective, double-blind, controlled trial in transcutaneous therapy for organic impotence.
    Cavallini G
    Int J Impot Res; 1994 Dec; 6(4):205-12. PubMed ID: 7795721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minoxidil versus nitroglycerin: a prospective double-blind controlled trial in transcutaneous erection facilitation for organic impotence.
    Cavallini G
    J Urol; 1991 Jul; 146(1):50-3. PubMed ID: 1905361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dionysos plaster or gunpowder without bullets].
    Wolf HI
    Ugeskr Laeger; 2008 Apr; 170(16):1375; author reply 1375. PubMed ID: 18441605
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-invasive management of impotence with transcutaneous nitroglycerin.
    Meyhoff HH; Rosenkilde P; Bødker A
    Br J Urol; 1992 Jan; 69(1):88-90. PubMed ID: 1737261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcutaneous nitroglycerin therapy in the treatment of impotence.
    Claes H; Baert L
    Urol Int; 1989; 44(5):309-12. PubMed ID: 2508287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of transdermal nitroglycerin and intracavernous injection of papaverine in the treatment of erectile dysfunction in patients with spinal cord lesions.
    Renganathan R; Suranjan B; Kurien T
    Spinal Cord; 1997 Feb; 35(2):99-103. PubMed ID: 9044517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical nitroglycerin: a potential treatment for impotence.
    Owen JA; Saunders F; Harris C; Fenemore J; Reid K; Surridge D; Condra M; Morales A
    J Urol; 1989 Mar; 141(3):546-8. PubMed ID: 2493100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of MED2005, a Topical Glyceryl Trinitrate Formulation, in the Treatment of Erectile Dysfunction: A Randomized Crossover Study.
    Ralph DJ; Eardley I; Taubel J; Terrill P; Holland T
    J Sex Med; 2018 Feb; 15(2):167-175. PubMed ID: 29306609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroglycerin ointment in the treatment of impotence.
    Nunez BD; Anderson DC
    J Urol; 1993 Oct; 150(4):1241-3. PubMed ID: 8371404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy.
    Engel JD; McVary KT
    Urology; 1998 May; 51(5):687-92. PubMed ID: 9610580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon.
    Hummers LK; Dugowson CE; Dechow FJ; Wise RA; Gregory J; Michalek J; Yenokyan G; McGready J; Wigley FM
    Ann Rheum Dis; 2013 Dec; 72(12):1962-7. PubMed ID: 23268365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled, efficacy and safety study of topical gel formulation of 1% alprostadil (Topiglan) for the in-office treatment of erectile dysfunction.
    Goldstein I; Payton TR; Schechter PJ
    Urology; 2001 Feb; 57(2):301-5. PubMed ID: 11182341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of the transdermal application of testosterone gel to the penile skin for the treatment of hypogonadotropic men with erectile dysfunction.
    Schultheiss D; Hiltl DM; Meschi MR; Machtens SA; Truss MC; Stief CG; Jonas U
    World J Urol; 2000 Dec; 18(6):431-5. PubMed ID: 11204264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erection, erectile dysfunction: what has heart got to do with it?
    Khandheria BK
    Herz; 2003 Jun; 28(4):275-6. PubMed ID: 12916517
    [No Abstract]   [Full Text] [Related]  

  • 16. A prospective, randomized, placebo-controlled trial of on-Demand vs. nightly sildenafil citrate as assessed by Rigiscan and the international index of erectile function.
    Kim DJ; Hawksworth DJ; Hurwitz LM; Cullen J; Rosner IL; Lue TF; Dean RC
    Andrology; 2016 Jan; 4(1):27-32. PubMed ID: 26663669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study.
    Wessells H; Fuciarelli K; Hansen J; Hadley ME; Hruby VJ; Dorr R; Levine N
    J Urol; 1998 Aug; 160(2):389-93. PubMed ID: 9679884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind crossover study evaluating the efficacy of korean red ginseng in patients with erectile dysfunction: a preliminary report.
    Hong B; Ji YH; Hong JH; Nam KY; Ahn TY
    J Urol; 2002 Nov; 168(5):2070-3. PubMed ID: 12394711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical treatment of erectile dysfunction: randomised double blind placebo controlled trial of cream containing aminophylline, isosorbide dinitrate, and co-dergocrine mesylate.
    Gomaa A; Shalaby M; Osman M; Eissa M; Eizat A; Mahmoud M; Mikhail N
    BMJ; 1996 Jun; 312(7045):1512-5. PubMed ID: 8646143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oral yohimbine/L-arginine combination (NMI 861) for the treatment of male erectile dysfunction: a pharmacokinetic, pharmacodynamic and interaction study with intravenous nitroglycerine in healthy male subjects.
    Kernohan AF; McIntyre M; Hughes DM; Tam SW; Worcel M; Reid JL
    Br J Clin Pharmacol; 2005 Jan; 59(1):85-93. PubMed ID: 15606445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.